Article

Top Tweets from #APhA 2017

Conference|APhA Annual Meeting and Exposition - American Pharmacists Association Annual Meeting and Exposition

Thanks for following us on Twitter, Instagram, and Facebook!

Social media sharing was a key component of the American Pharmacists Association (APhA) 2017 Annual Meeting & Exposition (APhA2017) in San Francisco, and Pharmacy Times was honored to be mentioned by so many of our followers. The following is a list of some of our favorite mentions:

Related Videos
Woman experiencing pain related to recurrent pericarditis -- Image credit: Art_Photo | stock.adobe.com
Pharmacist assisting a patient with pericarditis -- Image credit: Yuri Arcurs/peopleimages.com | stock.adobe.com
Related Content
Lower back pain, cLLD -- Image credit: JaRiRiyawat | stock.adobe.com
February 23rd 2025

FDA Grants Fast Track Designation to BRTX-100 to Treat Chronic Lumbar Disc Disease

Gillian McGovern, Associate Editor
Pharmacy Focus: GLP-1 Medications and Pharmacists' Role in Counseling Patients
January 31st 2025

Pharmacy Focus: GLP-1 Medications and Pharmacists' Role in Counseling Patients

Luke Halpern, Assistant Editor
Amlodipine tablets | Image Credit: © Ming - stock.adobe.com
February 21st 2025

A Common Blood Pressure Medication May Help Treat Symptoms of ADHD

Alexandra Gerlach, Associate Editor
Public Health Matters: The Importance of Reproductive Justice and Black Maternal Health
December 24th 2024

Public Health Matters: The Importance of Reproductive Justice and Black Maternal Health

Christina M. Madison, PharmD, FCCP, AAHIVP
A crosssection of a foot showing the progression of diabetic foot ulcers - Image credit: Moviebirth | stock.adobe.com
February 21st 2025

FDA Grants Breakthrough Therapy Designation to SkinTE for Diabetic Foot Ulcers

Kennedy Ferruggia, Assistant Editor
FDA approval stamp for chenodiol -- Image credit: Olivier Le Moal | stock.adobe.com
Published: February 21st 2025 | Updated: February 21st 2025

Chenodiol, First Treatment for Cerebrotendinous Xanthomatosis, Receives FDA Approval

Gillian McGovern, Associate Editor